Guidelines on the use of stable iodine as a prophylactic measure during nuclear emergencies

Among the fission products that may be released in a power reactor accident the radioiodines are unique in that the dose received by persons exposed by inhalation of radioiodines in the gaseous plume may be substantially reduced. GMA-9 provides guidance on the medical aspects of the use of stable iodine compounds as a prophylactic measure in the event of a nuclear accident. A review of the physiologic basis for the use of stable iodine as a prophylatic measure and the effects of radiation on the thyroid gland are provided. Logistic factors that must be considered to provide the optimum level of radiological protection and medical safety are also addressed. Due to the delay in publishing the French version of this report, some sections of this report have been updated to reflect current practices.71 refs., 6 tabs., 2 figs